Zika Hearing Shows How Vaccine Timelines Are Outbreak-Dependent
This article was originally published in The Pink Sheet Daily
Executive Summary
NIAID appears on track to have Zika vaccine in widespread testing in late 2017, but development depends in part on the epidemic rate; additional funding is necessary to respond to the outbreak, NIAID director and CDC official testify at Senate and House hearings.